Sartorius opens new application center in Shanghai
3 November 2014 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new application center at its Shanghai office last week...
List view / Grid view
News
Syrris Asia helps to accelerate spirocyclic polyketide synthesis
3 November 2014 | By kdm communications
The modular Asia flow chemistry system from Syrris proved key to the success of a recently described process for accelerated total synthesis of spirodienal A and spirangien A methyl ester...
Nagoya University’s ITbM, Japan, licenses Cresset’s computational chemistry software to accelerate their research
3 November 2014 | By kdm communications
Cresset, innovative provider of computational chemistry software and services, is pleased to announce that Nagoya University’s Institute of Transformative Bio-Molecules (ITbM)...
Auspherix secures additional AU$1million from MRCF to advance its antibiotic pipeline
3 November 2014 | By Auspherix Pty Ltd
Auspherix Pty Ltd, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial disease has secured a further with AU$1 million in a series A financing from Australia’s Medical Research Commercialisation Fund (MRCF), to progress its antibacterial compounds through development studies...
European Medicines Agency accepts Marketing Authorization Application for Oleogel-S10
3 November 2014 | By Birken
Birken AG, a biopharmaceutical and dermo-cosmetic company, announces that the European Medicines Agency has accepted its Oleogel-S10 Marketing Authorization Application for review...
BioOutsource ramps up investment in R&D to prepare for biosimilars boom
3 November 2014 | By BioOutsource Ltd
BioOutsource Ltd. announced a major initiative in new research and development programs to support the next generation of biosimilars...
Almirall completes deal with Astrazeneca in respiratory disease
3 November 2014 | By Almirall
Almirall announced that, effective November 1st, it has completed the transaction to transfer to AstraZeneca the rights of Almirall’s respiratory franchise after all closing conditions have been satisfied...
Bristol-Myers Squibb’s ZymoGenetics R&D facility earns LEED Silver Certification from U.S. Green Building Council
31 October 2014 | By Bristol-Myers Squibb
ZymoGenetics is among an elite group of laboratories around the world that have earned the U.S. Green Building Council’s LEED® (Leadership in Energy and Environmental Design) Silver certification for Existing Buildings: Operations and Maintenance...
Actinogen Ltd acquires Edinburgh BioQuarter spin-out to develop treatment for Alzheimer’s dementia
31 October 2014 | By Actinogen Ltd
Actinogen Ltd, an Australian biotechnology company, has acquired Edinburgh BioQuarter spin-out, Corticrine Ltd in a deal facilitated and introduced by Professor Alan Boyd of Boyds...
Bristol-Myers Squibb and Lonza expand biologics manufacturing agreement
Bristol-Myers Squibb Company and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire. Financial terms were not disclosed.
New Genital Herpes vaccine entrants require improved efficacy to compete, says GlobalData analyst
31 October 2014 | By GlobalData
While the collaboration between Sanofi Pasteur (Sanofi) and Immune Design to develop a genital herpes vaccine presents a strong scientific foundation and difficult-to-match financial clout, the partnership needs to create a product with better clinical performance to compete with more advanced pipeline vaccine candidates, says an analyst with research and…
Phase 2 data for Opdivo (nivolumab) to be presented
30 October 2014 | By Bristol-Myers Squibb
Phase 2 objective response rate and survival data for Opdivo (nivolumab) in heavily pre-treated advanced squamous cell non-small cell lung cancer to be presented at the 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology...
Auditing is theme for next BGMA Quality Forum
Auditing will be a key theme of the British Generic Manufacturers Association’s (BGMA) next BGMA Quality Forum meeting on Wednesday, November 12th which is run in partnership with the MHRA.
Lilly shares technology insights to increase supply of medicines for multidrug-resistant tuberculosis
30 October 2014 | By Eli Lilly and Company
Eli Lilly and Company published details of its long-standing technology transfer program to increase the global supply of medicines for multidrug-resistant tuberculosis (MDR-TB)...
Celebrating the best of pharma and recognizing companies that turn inspiration into innovation
30 October 2014 | By PresseBox
It has become a tradition to recognize pharma innovation at CPhI Worldwide, as CPhI Pharma awards winners driving Pharma's biggest innovations...
